ICONIC THERAPEUTICS INC has a total of 32 patent applications. It increased the IP activity by 33.0%. Its first patent ever was published in 2004. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are ULTIMOVACS AS, PLATELET TARGETED THERAPEUTICS LLC and PROTOX THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 7 | |
#2 | EPO (European Patent Office) | 5 | |
#3 | United States | 5 | |
#4 | Canada | 3 | |
#5 | Australia | 2 | |
#6 | Brazil | 2 | |
#7 | China | 2 | |
#8 | Republic of Korea | 2 | |
#9 | Israel | 1 | |
#10 | Mexico | 1 | |
#11 | Singapore | 1 | |
#12 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Foods and drinks | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Enzymes | |
#5 | Microorganisms | |
#6 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Dornbush Kirk | 17 |
#2 | Greene William | 13 |
#3 | Burian Gabriela | 13 |
#4 | Migone Thi-Sau | 12 |
#5 | Theunissen Jan-Willem | 8 |
#6 | Cai Allen G | 6 |
#7 | Trown Patrick W | 4 |
#8 | Cooper Anthony Byron | 4 |
#9 | Sherman Michael I | 4 |
#10 | William Greene | 2 |
Publication | Filing date | Title |
---|---|---|
WO2021003399A1 | Anti-tissue factor antibody-drug conjugates and related methods | |
KR20200118029A | Anti-tissue factor antibodies, antibody-drug conjugates, and related methods | |
TW201836646A | Methods for treating disorders associated with angiogenesis and neovascularization | |
EP3442554A1 | Compositions and methods for treating disorders associated with neovascularization | |
WO2017083791A1 | Methods and compositions for treating disorders associated with pathological neovascularization | |
AU2016297178A1 | Methods for treating disorders associated with angiogenesis and neovascularization | |
WO2005051289A2 | Homogeneous preparations of chimeric proteins |